Melatonin Neuraxpharm

Melatonin, the active ingredient in Melatonin Neuraxpharm, is a melatonin receptor agonist presented as an oral formulation for oral use. It is used to support normal sleep patterns in adults experiencing sleep disturbances. GNH USA supplies Melatonin Neuraxpharm as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melatonin Neuraxpharm acts on the melatonin MT1 and MT2 receptors to help regulate the sleep‑wake cycle. - Insomnia: assists individuals in falling asleep more quickly and improving sleep continuity. - Jet lag: aids adjustment of the circadian rhythm after rapid travel across time zones. - Shift work disorder: promotes sleep during daytime hours for workers on non‑traditional schedules.

Melatonin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Drowsiness or daytime sleepiness - Headache - Dizziness - Nausea - Vivid dreams or nightmares

Serious or Rare Side Effects: - Allergic reactions such as rash, itching, or swelling - Mood changes including depression or anxiety - Hormonal effects like menstrual irregularities - Severe hypotension (very low blood pressure)

Melatonin should be used with awareness of certain safety considerations. - Pregnancy: consult a healthcare professional before use. - Breastfeeding: discuss potential risks with a physician. - Concomitant anticoagulant therapy: monitor for increased bleeding tendency. - Driving or operating machinery: may cause drowsiness; caution is advised. - Known hypersensitivity: avoid if allergic to melatonin or excipients. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Melatonin may interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - CYP1A2 inhibitors (e.g., fluvoxamine): can raise melatonin plasma levels. - Anticoagulants (e.g., warfarin): may enhance bleeding risk.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines): additive sedative effect. - Oral contraceptives: may increase melatonin concentrations. - Antidepressants (SSRIs): possible alteration of sleep architecture.